The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis
2004 · Proceedings of the National Academy of Sciences · 72 citations
https://doi.org/10.1073/pnas.0308065101
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
101
Papers
15.0K
Citations
38
h-index
43
i10-index
Jocelyn Holash is an academic researcher from Novartis (Switzerland). The author has contributed to research in topics: Angiogenesis and VEGF in Cancer & Cancer, Hypoxia, and Metabolism & Ubiquitin and proteasome pathways. The author has an h-index of 38, co-authored 86 publications.
https://doi.org/10.1073/pnas.0308065101
https://doi.org/10.1007/s10555-006-8504-6
Click to start Chat